• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

茶碱消除率的稳定性。

Stability of theophylline elimination rate.

作者信息

Milavetz G, Vaughan L M, Weinberger M M

出版信息

Clin Pharmacol Ther. 1987 Apr;41(4):388-91. doi: 10.1038/clpt.1987.46.

DOI:10.1038/clpt.1987.46
PMID:3549119
Abstract

The elimination rate for theophylline varies greatly among patients, but recommendations for maintenance dosing schedules have assumed relatively little intrapatient variability even over extended time periods. Reports of large intrapatient variability of theophylline elimination rate and consequent clearance raise concerns regarding this assumption and also challenge the practice of assuming relative constancy of elimination rate in the performance of bioavailability studies of slow-release formulations. We therefore systematically studied under controlled conditions the elimination rate of theophylline in 10 patients over an extended time interval. The initial elimination rate constants ranged from 0.062 to 0.136 hours-1. The changes ranged from -5.9% to 9.4% of the initial value during intervals of 2 to 11 months. Correlation of the first and second values was 0.96. Thus the elimination rate of theophylline generally appears to vary little within individuals over time when studied under controlled conditions.

摘要

茶碱的消除率在患者之间差异很大,但维持给药方案的建议即使在较长时间段内也假定患者体内的变异性相对较小。关于茶碱消除率和随之而来的清除率在患者体内存在较大变异性的报告引发了对这一假设的担忧,同时也对在缓释制剂生物利用度研究中假设消除率相对恒定的做法提出了挑战。因此,我们在受控条件下系统地研究了10名患者在较长时间间隔内茶碱的消除率。初始消除速率常数范围为0.062至0.136小时-1。在2至11个月的间隔期间,变化范围为初始值的-5.9%至9.4%。第一个值和第二个值的相关性为0.96。因此,在受控条件下进行研究时,茶碱的消除率在个体内随时间推移通常变化很小。

相似文献

1
Stability of theophylline elimination rate.茶碱消除率的稳定性。
Clin Pharmacol Ther. 1987 Apr;41(4):388-91. doi: 10.1038/clpt.1987.46.
2
A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.缓释型茶碱产品选用的临床及药代动力学依据
Clin Pharmacokinet. 1984 Mar-Apr;9(2):95-135. doi: 10.2165/00003088-198409020-00001.
3
New method for bioavailability assessment of slow-release preparations of theophylline.
J Pharmacokinet Biopharm. 1985 Dec;13(6):571-87. doi: 10.1007/BF01058902.
4
Theophylline for chronic asthma: rationale for treatment, product selection, and dosage schedule.用于慢性哮喘的茶碱:治疗原理、产品选择及给药方案
Pediatr Pharmacol (New York). 1983;3(3-4):273-85.
5
The relation of product formulation to absorption of oral theophylline.产品配方与口服茶碱吸收的关系。
N Engl J Med. 1978 Oct 19;299(16):852-7. doi: 10.1056/NEJM197810192991603.
6
Clinical and pharmacokinetic concerns of 24-hour dosing with theophylline.氨茶碱24小时给药的临床及药代动力学问题
Ann Allergy. 1986 Jan;56(1):2-12.
7
Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II.
Int J Clin Pharmacol Ther Toxicol. 1986 Apr;24(4):196-201.
8
Pharmacokinetic properties of a new sustained-release theophylline preparation.一种新型茶碱缓释制剂的药代动力学特性
Int J Clin Pharmacol Ther Toxicol. 1983 Feb;21(2):69-72.
9
Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.囊性纤维化患者中茶碱的药代动力学及缓释茶碱制剂的生物利用度
Ann Allergy. 1983 Mar;50(3):161-5.
10
Dose dependency for absorption and elimination rates of theophylline. Implications for studies of bioavailability.茶碱吸收与消除速率的剂量依赖性。对生物利用度研究的启示。
Pharmacotherapy. 1984 Jul-Aug;4(4):216-20. doi: 10.1002/j.1875-9114.1984.tb03361.x.

引用本文的文献

1
Effects of alpha-interferon on theophylline pharmacokinetics and metabolism.α-干扰素对茶碱药代动力学及代谢的影响。
Br J Clin Pharmacol. 1989 Jun;27(6):795-802. doi: 10.1111/j.1365-2125.1989.tb03442.x.